Follow-up Trial to Evaluate Long-term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Status:
Completed
Trial end date:
2019-05-01
Target enrollment:
Participant gender:
Summary
This trial, evaluating the long-term safety and tolerability of brivaracetam, will give
subjects suffering from epilepsy, who may have benefited from brivaracetam, the opportunity
to continue the treatment. The study will also evaluate the maintenance of efficacy over time
of brivaracetam for subjects with partial onset seizures (POS)/primary generalized seizures
(PGS).